In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Aquestive Therapeutics Inc (NASDAQ: AQST) was $3.41 for the day, down -4.75% from the previous closing price of $3.58. In other words, the price has decreased by -$4.75 from its previous closing price. On the day, 1.22 million shares were traded.
Ratios:
Our analysis of AQST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.48 and its Current Ratio is at 4.87.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $17.
On May 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $8.Leerink Partners initiated its Outperform rating on May 10, 2024, with a $8 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 26 ’24 when Jung Cassie sold 44 shares for $4.87 per share. The transaction valued at 214 led to the insider holds 0 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.25.
Stock Price History:
Over the past 52 weeks, AQST has reached a high of $5.80, while it has fallen to a 52-week low of $2.12. The 50-Day Moving Average of the stock is 23.54%, while the 200-Day Moving Average is calculated to be -7.43%.
Shares Statistics:
A total of 99.32M shares are outstanding, with a floating share count of 91.68M. Insiders hold about 7.70% of the company’s shares, while institutions hold 42.63% stake in the company.
